WeAreTechWomen | Inspirational Woman: Phyllis Meng

Malaysia's MDA and China's NMPA have launched Pilot Phase 2 of the Malaysia-China Joint Evaluation Pilot Programme, open from 1 July to 30 September 2026. The programme enables simultaneous evaluation of eligible medical devices under the GHWP CERP framework to reduce duplicative review and support faster access to both markets.

The Philippine Department of Health has extended the suspension of higher medical device registration fees for another 120 working days from 2 June 2026, keeping CMDR applications under the current lower government fee schedule while Administrative Order No. 2024-0016 remains suspended.

Starting 1 July 2026, Australia's TGA has updated fees and annual charges for medical devices and IVDs, including ARTG application assessments, audit fees, annual charges, and Annual Charge Exemption deadlines. Manufacturers and Australian Sponsors should review portfolio status and payment timelines to avoid unnecessary costs or ARTG disruption.